Related Experiment Video
Updated: Mar 18, 2026
08:30
MicroRNA Detection in Prostate Tumors by Quantitative Real-time PCR qPCR
Published on: May 16, 2012
25.1K
TRPM8 Puts the Chill on Prostate Cancer
Guillaume P Grolez1, Dimitra Gkika2
1Laboratoire de Physiologie cellulaire, Inserm U1003, Laboratory of Excellence, Ion Channels Science and Therapeutics, Université de Lille, 59655 Villeneuve d'Ascq Cedex, France. guillaume.grolez@etudiant.univ-lille1.fr.
Pharmaceuticals (Basel, Switzerland)
|July 14, 2016
Summary
The Transient Receptor Potential Melastatin member 8 (TRPM8) channel is implicated in prostate cancer (PCa) development. Understanding TRPM8
Area of Science:
- Oncology
- Molecular Biology
- Calcium Signaling
Background:
- Prostate cancer (PCa) is a prevalent malignancy in developed nations.
- Alterations in calcium homeostasis are linked to cancer development.
- TRPM8 channel expression varies during prostate carcinogenesis, suggesting a role in PCa progression.
Purpose of the Study:
- To review current knowledge on the role of the TRPM8 channel in prostate cancer initiation and progression.
- To highlight TRPM8's involvement in key cellular processes relevant to PCa evolution.
Main Methods:
- Literature review of studies investigating TRPM8 in prostate cancer.
- Analysis of research on TRPM8's function in cell proliferation, viability, and migration.
- Examination of TRPM8's potential as a therapeutic target in PCa.
Main Results:
- TRPM8 channels are differentially expressed during prostate carcinogenesis.
- TRPM8 influences PCa cell proliferation, viability, and migration.
- TRPM8 exhibits an anti-invasive effect on cell migration, indicating therapeutic potential.
Conclusions:
- TRPM8 plays a significant role in prostate cancer progression.
- TRPM8's function in cell migration suggests it is a promising therapeutic target for PCa.
- Further research into TRPM8 modulation could lead to novel PCa treatments.
